List of Excipients in API darifenacin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing darifenacin
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Allergan Inc | ENABLEX | darifenacin | 0430-0170 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | |
Allergan Inc | ENABLEX | darifenacin | 0430-0170 | HYPROMELLOSES | |
Allergan Inc | ENABLEX | darifenacin | 0430-0170 | MAGNESIUM STEARATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing darifenacin
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 | CELLULOSE, MICROCRYSTALLINE |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 | HYPROMELLOSE 2208 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 | HYPROMELLOSE 2910 |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for darifenacin
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
darifenacin drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Company | Ingredient | NDC |
---|---|---|
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
>Company | >Ingredient | >NDC |
Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
darifenacin drug variants containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
darifenacin drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
darifenacin drug variants containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
darifenacin drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Aurobindo Pharma Limited | darifenacin | 65862-861 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
darifenacin drug variants containing ETHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Aurobindo Pharma Limited | darifenacin | 65862-861 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing ETHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
darifenacin drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
darifenacin drug variants containing HYDROXYETHYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Aurobindo Pharma Limited | darifenacin | 65862-861 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYDROXYETHYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
darifenacin drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Aurobindo Pharma Limited | darifenacin | 65862-861 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
darifenacin drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
Physicians Total Care Inc | darifenacin | 54868-5704 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
darifenacin drug variants containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
Xiromed LLC | darifenacin hydrobromide | 70700-182 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
darifenacin drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Aurobindo Pharma Limited | darifenacin | 65862-861 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
darifenacin drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
darifenacin drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Aurobindo Pharma Limited | darifenacin | 65862-861 |
Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
darifenacin drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
darifenacin drug variants containing MALTODEXTRIN
Company | Ingredient | NDC |
---|---|---|
Xiromed LLC | darifenacin hydrobromide | 70700-182 |
Alan Laboratories Inc | darifenacin hydrobromide | 70754-161 |
Proficient Rx LP | darifenacin hydrobromide | 71205-900 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing MALTODEXTRIN
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
darifenacin drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
Xiromed LLC | darifenacin hydrobromide | 70700-182 |
Alan Laboratories Inc | darifenacin hydrobromide | 70754-161 |
Proficient Rx LP | darifenacin hydrobromide | 71205-900 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
darifenacin drug variants containing POLYDEXTROSE
Company | Ingredient | NDC |
---|---|---|
Xiromed LLC | darifenacin hydrobromide | 70700-182 |
Alan Laboratories Inc | darifenacin hydrobromide | 70754-161 |
Proficient Rx LP | darifenacin hydrobromide | 71205-900 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYDEXTROSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
darifenacin drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
Physicians Total Care Inc | darifenacin | 54868-5704 |
Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 1500
darifenacin drug variants containing POLYETHYLENE GLYCOL 1500
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 1500
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 200
darifenacin drug variants containing POLYETHYLENE GLYCOL 200
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 200
Company | Ingredient | NDC |
---|---|---|
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
darifenacin drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
POLYGEN PHARMACEUTICALS INC | darifenacin hydrobromide | 52605-067 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
darifenacin drug variants containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
Cipla USA Inc | darifenacin hydrobromide | 69097-431 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
darifenacin drug variants containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Aurobindo Pharma Limited | darifenacin | 65862-861 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
darifenacin drug variants containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Jubilant Cadista Pharmaceuticals Inc | darifenacin hydrobromide | 59746-516 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
darifenacin drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Par Pharmaceutical Inc | darifenacin hydrobromide | 10370-170 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
darifenacin drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
Alembic Pharmaceuticals Inc | darifenacin | 62332-223 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
darifenacin drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
Rising Pharma Holdings Inc | darifenacin | 16571-767 |
Macleods Pharmaceuticals Limited | darifenacin | 33342-276 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Alembic Pharmaceuticals Limited | darifenacin | 46708-223 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
darifenacin drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
darifenacin drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | darifenacin | 0430-0170 |
Actavis Pharma Inc | darifenacin | 0591-4375 |
Torrent Pharmaceuticals Limited | darifenacin | 13668-202 |
>Company | >Ingredient | >NDC |
darifenacin drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.